TheraSense shares up 30% on day one:
This article was originally published in Clinica
Executive Summary
Shares in blood glucose monitoring company TheraSense rose over 30% to nearly $25 on their first day of trading on the Nasdaq. The Alameda, California company floated earlier this month, raising $114 million (see Clinica No 979, p 15).